{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T10:44:31Z","timestamp":1755600271088,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T00:00:00Z","timestamp":1528761600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Healthc Inform Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s41666-018-0027-8","type":"journal-article","created":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T11:24:20Z","timestamp":1528802660000},"page":"353-366","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Estimation of Lead Time via Low-Dose CT in the National Lung Screening Trial"],"prefix":"10.1007","volume":"2","author":[{"given":"Ruiqi","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6764-0083","authenticated-orcid":false,"given":"Dongfeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,12]]},"reference":[{"key":"27_CR1","unstructured":"The health consequences of smoking\u201450 years of progress.(2014) A report of the surgeon general. \nhttp:\/\/www.surgeongeneral.gov\/library\/reports\/50-years-of-progress\/full-report.pdf\n\n. Accessed 15 Oct 2017"},{"key":"27_CR2","unstructured":"Lung cancer stages.(2017). \nhttps:\/\/www.cancercenter.com\/lung-cancer\/stages\/\n\n. Accessed 22 March 2018"},{"key":"27_CR3","unstructured":"SEER Fast Stats Results, NIH. (2017).\nhttp:\/\/seer.cancer.gov\/statfacts\/html\/lungb.html\n\n. Accessed 15 Oct 2017"},{"issue":"5","key":"27_CR4","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/S0025-6196(11)60735-0","volume":"83","author":"JR Molina","year":"2008","unstructured":"Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA (2008) Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 83(5):584\u2013594","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"27_CR5","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1378\/chest.67.5.511","volume":"67","author":"RS Fontana","year":"1975","unstructured":"Fontana RS, Sanderson DR, Woolner LB, Miller WE, Bernatz PE, Payne WS, Taylor WF (1975) The Mayo Lung Project for early detection and localization of bronchogenic carcinoma: a status report. CHEST 67(5):511\u2013522. \nhttps:\/\/doi.org\/10.1378\/chest.67.5.511","journal-title":"CHEST"},{"issue":"3","key":"27_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jegh.2013.05.001","volume":"3","author":"H Jang","year":"2013","unstructured":"Jang H, Kim S, Wu D (2013) Bayesian lead time estimation for the Johns Hopkins Lung Project data. J Epidemiol Glob Health 3(3):157\u2013163. \nhttps:\/\/doi.org\/10.1016\/j.jegh.2013.05.001","journal-title":"J Epidemiol Glob Health"},{"issue":"4","key":"27_CR7","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1164\/arrd.1984.130.4.555","volume":"130","author":"BJ Flehinger","year":"1984","unstructured":"Flehinger BJ, Melamed MR, Zaman MB, Heelan RT, Perchick WB, Martini N (1984) Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Memorial Sloan-Kettering study. Am Rev Respir Dis 130(4):555\u2013560. \nhttps:\/\/doi.org\/10.1164\/arrd.1984.130.4.555","journal-title":"Am Rev Respir Dis"},{"issue":"9173","key":"27_CR8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0140-6736(99)06093-6","volume":"354","author":"CI Henschke","year":"1999","unstructured":"Henschke CI, McCauley DI, Yankelevitz DF, Naidich DP, McGuinness G, Miettinen OS, Libby DM, Pasmantier MW, Koizumi J, Altorki NK, Smith JP (1999) Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 354(9173):99\u2013105. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(99)06093-6","journal-title":"Lancet"},{"issue":"1","key":"27_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/1097-0142(20010701)92:1<153::AID-CNCR1303>3.0.CO;2-S","volume":"92","author":"I Henschke Claudia","year":"2001","unstructured":"Henschke Claudia I, Naidich David P, Yankelevitz David F, McGuinness G, McCauley Dorothy I, Smith James P, Libby D, Pasmantier M, Vazquez M, Koizumi J, Flieder D, Altorki N, Miettinen Olli S (2001) Early Lung Cancer Action Project: initial findings on repeat screenings. Cancer 92(1):153\u2013159. \nhttps:\/\/doi.org\/10.1002\/1097-0142(20010701)92:1<153::AID-CNCR1303>3.0.CO;2-S","journal-title":"Cancer"},{"issue":"6, Supplement 1","key":"27_CR10","doi-asserted-by":"publisher","first-page":"273S","DOI":"10.1016\/S0197-2456(00)00098-2","volume":"21","author":"PC Prorok","year":"2000","unstructured":"Prorok PC, Andriole GL, Bresalier RS, Buys SS, Chia D, David Crawford E, Fogel R, Gelmann EP, Gilbert F, Hasson MA, Hayes RB, Johnson CC, Mandel JS, Oberman A, O'Brien B, Oken MM, Rafla S, Reding D, Rutt W, Weissfeld JL, Yokochi L, Gohagan JK (2000) Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials 21(6, Supplement 1):273S\u2013309S. \nhttps:\/\/doi.org\/10.1016\/S0197-2456(00)00098-2","journal-title":"Control Clin Trials"},{"issue":"6, Supplement 1","key":"27_CR11","doi-asserted-by":"publisher","first-page":"251S","DOI":"10.1016\/S0197-2456(00)00097-0","volume":"21","author":"JK Gohagan","year":"2000","unstructured":"Gohagan JK, Prorok PC, Hayes RB, Kramer B-S (2000) The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. Control Clin Trials 21(6, Supplement 1):251S\u2013272S. \nhttps:\/\/doi.org\/10.1016\/S0197-2456(00)00097-0","journal-title":"Control Clin Trials"},{"issue":"5","key":"27_CR12","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJMoa1102873","volume":"365","author":"National Lung Screening Trial Research Team","year":"2011","unstructured":"National Lung Screening Trial Research Team (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365(5):395\u2013409. \nhttps:\/\/doi.org\/10.1056\/NEJMoa1102873","journal-title":"N Engl J Med"},{"issue":"1","key":"27_CR13","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.chest.2017.03.019","volume":"152","author":"Y Shieh","year":"2017","unstructured":"Shieh Y, Bohnenkamp M (2017) Low-dose CT scan for lung cancer screening: clinical and coding considerations. CHEST 152(1):204\u2013209. \nhttps:\/\/doi.org\/10.1016\/j.chest.2017.03.019","journal-title":"CHEST"},{"issue":"1","key":"27_CR14","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1148\/radiol.10091808","volume":"258","author":"National Lung Screening Trial Research Team","year":"2011","unstructured":"National Lung Screening Trial Research Team (2011) The National Lung Screening Trial: overview and study design. Radiology 258(1):243\u2013253. \nhttps:\/\/doi.org\/10.1148\/radiol.10091808","journal-title":"Radiology"},{"key":"27_CR15","unstructured":"Final update summary: lung cancer: screening. (2015). U.S. Preventive Services Task Force. July 2015. \nhttps:\/\/www.uspreventiveservicestaskforce.org\/Page\/Document\/UpdateSummaryFinal\/lung-cancer-screening\n\n. Accessed 15 Oct 2017"},{"issue":"5","key":"27_CR16","doi-asserted-by":"publisher","first-page":"330","DOI":"10.7326\/M13-2771","volume":"160","author":"VA Moyer","year":"2014","unstructured":"Moyer VA, on behalf of the U.S. Preventive Services Task Force (2014) Screening for lung cancer: U.S.. Preventive Services Task Force recommendation statement. Ann Intern Med 160(5):330\u2013338. \nhttps:\/\/doi.org\/10.7326\/M13-2771","journal-title":"Ann Intern Med"},{"issue":"3","key":"27_CR17","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1111\/j.1541-0420.2006.00732.x","volume":"63","author":"D Wu","year":"2007","unstructured":"Wu D, Rosner GL, Broemeling LD (2007) Bayesian inference for the lead time in periodic cancer screening. Biometrics 63(3):873\u2013880. \nhttps:\/\/doi.org\/10.1111\/j.1541-0420.2006.00732.x","journal-title":"Biometrics"},{"issue":"5\u20137","key":"27_CR18","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/sim.4780130519","volume":"13","author":"K Kafadar","year":"1994","unstructured":"Kafadar K, Prorok Philip C (1994) A data-analytic approach for estimating lead time and screening benefit based on survival curves in randomized cancer screening trials. Stat Med 13(5\u20137):569\u2013586. \nhttps:\/\/doi.org\/10.1002\/sim.4780130519","journal-title":"Stat Med"},{"issue":"2","key":"27_CR19","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0167-9473(96)00029-1","volume":"23","author":"K Kafadar","year":"1996","unstructured":"Kafadar K, Prorok PC (1996) Computer simulation of randomized cancer screening trials to compare methods of estimating lead time and benefit time. Comput Stat Data Anal 23(2):263\u2013291. \nhttps:\/\/doi.org\/10.1016\/S0167-9473(96)00029-1","journal-title":"Comput Stat Data Anal"},{"issue":"1","key":"27_CR20","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/sim.1331","volume":"22","author":"K Kafadar","year":"2003","unstructured":"Kafadar K, Prorok Philip C (2003) Alternative definitions of comparable case groups and estimates of lead time and benefit time in randomized cancer screening trials. Stat Med 22(1):83\u2013111. \nhttps:\/\/doi.org\/10.1002\/sim.1331","journal-title":"Stat Med"},{"issue":"7","key":"27_CR21","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/(SICI)1521-4036(199811)40:7<801::AID-BIMJ801>3.0.CO;2-7","volume":"40","author":"K Kafadar","year":"1999","unstructured":"Kafadar K, Prorok Philip C, Smith Paul J (1999) An estimate of the variance of estimators for lead time and screening benefit time in randomized cancer screening trials. Biom J 40(7):801\u2013821. \nhttps:\/\/doi.org\/10.1002\/(SICI)1521-4036(199811)40:7<801::AID-BIMJ801>3.0.CO;2-7","journal-title":"Biom J"},{"issue":"1","key":"27_CR22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2307\/3213911","volume":"19","author":"PC Prorok","year":"1982","unstructured":"Prorok PC (1982) Bounded recurrence times and lead time in the design of a repetitive screening program. J Appl Probab 19(1):10\u201319. \nhttps:\/\/doi.org\/10.2307\/3213911","journal-title":"J Appl Probab"},{"key":"27_CR23","doi-asserted-by":"publisher","unstructured":"Wu D, Kafadar K, Rosner GL, Broemeling LD (2012) The lead time distribution when lifetime is subject to competing risks in cancer screening. Int J Biostat 8(1). \nhttps:\/\/doi.org\/10.1515\/1557-4679.1363","DOI":"10.1515\/1557-4679.1363"},{"key":"27_CR24","unstructured":"The United States Social Security Administration Actuarial Life Table. \nhttps:\/\/www.ssa.gov\/oact\/STATS\/table4c6.html\n\n. (2016). Accessed 10 Oct 2016"},{"issue":"3","key":"27_CR25","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.lungcan.2010.10.010","volume":"72","author":"D Wu","year":"2011","unstructured":"Wu D, Erwin D, Rosner GL (2011) Sojourn time and lead time projection in lung cancer screening. Lung Cancer 72(3):322\u2013326. \nhttps:\/\/doi.org\/10.1016\/j.lungcan.2010.10.010","journal-title":"Lung Cancer"},{"issue":"3","key":"27_CR26","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/biomet\/56.3.601","volume":"56","author":"M Zelen","year":"1969","unstructured":"Zelen M, Feinleib M (1969) On the theory of screening for chronic diseases. Biometrika 56(3):601\u2013614","journal-title":"Biometrika"},{"issue":"05","key":"27_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2155-6180.1000263","volume":"06","author":"R Liu","year":"2015","unstructured":"Liu R, Levitt B (2015) Bayesian estimation of the three key parameters in CT for the National Lung Screening Trial data. J Biom Biostatistics 06(05):1. \nhttps:\/\/doi.org\/10.4172\/2155-6180.1000263","journal-title":"J Biom Biostatistics"},{"key":"27_CR28","doi-asserted-by":"publisher","first-page":"263","DOI":"10.15446\/rce.v40n2.60642","volume":"40","author":"R Liu","year":"2017","unstructured":"Liu R, Gaskins JT, Mitra R, Wu D (2017) A review of estimation of key parameters and lead time in cancer screening. Rev Col Estad\u00edstica 40:263\u2013278","journal-title":"Rev Col Estad\u00edstica"},{"issue":"4","key":"27_CR29","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1111\/j.1541-0420.2005.00361.x","volume":"61","author":"D Wu","year":"2005","unstructured":"Wu D, Rosner GL, Broemeling L (2005) MLE and Bayesian inference of age-dependent sensitivity and transition probability in periodic screening. Biometrics 61(4):1056\u20131063. \nhttps:\/\/doi.org\/10.1111\/j.1541-0420.2005.00361.x","journal-title":"Biometrics"}],"container-title":["Journal of Healthcare Informatics Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s41666-018-0027-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s41666-018-0027-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s41666-018-0027-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T09:29:04Z","timestamp":1574760544000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s41666-018-0027-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,12]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["27"],"URL":"https:\/\/doi.org\/10.1007\/s41666-018-0027-8","relation":{},"ISSN":["2509-4971","2509-498X"],"issn-type":[{"type":"print","value":"2509-4971"},{"type":"electronic","value":"2509-498X"}],"subject":[],"published":{"date-parts":[[2018,6,12]]},"assertion":[{"value":"27 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The statements contained herein are solely those of the authors and do not represent or imply concurrence or endorsement by NCI.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}